Marek Jutel to Betula
This is a "connection" page, showing publications Marek Jutel has written about Betula.
Connection Strength
0.047
-
Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season. J Allergy Clin Immunol. 2018 08; 142(2):678-680.e7.
Score: 0.047
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.